Breaking News Instant updates and real-time market news.

CYNA

Cynapsus Therapeutics

$40.45

0.05 (0.12%)

16:04
10/13/16
10/13
16:04
10/13/16
16:04

Cynapsus holders approve plan of arrangement with Sunovion Pharmaceuticals

Cynapsus Therapeutics is pleased to announce that at its special meeting of shareholders and warrantholders held earlier today, Securityholders approved the special resolution authorizing the previously announced plan of arrangement with Sunovion Pharmaceuticals. Pursuant to the terms of the Arrangement, the Purchaser will acquire all of the outstanding (i) common shares of Cynapsus for US$40.50 cash per common share and (ii) warrants of Cynapsus for US$40.50 cash per warrant minus the exercise price of each warrant. As announced on August 31, the transaction values Cynapsus at approximately US$624 million. The Special Resolution was approved by approximately 99.97% of the common shares and warrants, voting together as one class, voted in person or represented by proxy at the Meeting, as well as by a "majority of the minority" as required pursuant to Multilateral Instrument 61-101. The implementation of the Arrangement remains subject to the granting of the final order by the Ontario Superior Court of Justice, the receipt of required regulatory approvals and the satisfaction or waiver of other customary closing conditions. The application to the Ontario Superior Court of Justice to obtain the final order approving the Arrangement is scheduled for October 17, 2016. If court approval is obtained and the other conditions to the completion of the Arrangement are satisfied or waived, Cynapsus expects that the Arrangement will be completed on or about October 21, 2016.Beneficial Securityholders are not required to take any action in respect of the completion of the Arrangement. The cash to be paid to beneficial Securityholders following completion of the Arrangement is expected to be credited to the beneficial Securityholders' broker, trustee, financial institution, dealer, bank, trust company, custodian, nominee or other intermediary account through the procedures in place for such purposes between CDS and such intermediaries. Beneficial Securityholders should contact their intermediary if they have any questions regarding this process. In order for a registered Securityholder to receive the cash consideration for the common shares or warrants following completion of the Arrangement, he, she or it must complete, sign, date and return the letter of transmittal, in accordance with the instructions set out therein that was mailed to all registered Securityholders in connection with the Meeting.

  • 13

    Oct

CYNA Cynapsus Therapeutics
$40.45

0.05 (0.12%)

07/19/16
JANY
07/19/16
NO CHANGE
Target $24
JANY
Buy
Cynapsus Phase 3 DTP results bode well for study, says Janney Capital
Janney Capital analyst Ken Trbovich believes the open-label dose titration phase, or DTP, results reported by Cynapsus Therapeutics support his expectation that the Phase 3 trial will likely result in a clinically and statistically significant difference from placebo during the randomized portion of the study. The analyst keeps a Buy rating and $24 fair value estimate on Cynapsus shares.
07/20/16
BMOC
07/20/16
NO CHANGE
BMOC
Cynapsus Therapeutics price target raised to $25 from $21 at BMO Capital
BMO Capital increased its price target on Cynapsus citing its belief that the company's APL drug will be approved in Europe. The firm keeps an Outperform rating on the shares.
08/16/16
BMOC
08/16/16
NO CHANGE
BMOC
Cynapsus Therapeutics price target raised to $30 from $25 at BMO Capital
BMO Capital analyst Do Kim raised his price target on Cynapsus after the Data and Safety Monitoring Board, or DSMB, said that patients participating in a trial of the company's APL at-home titration product could use it at home. The analyst thinks that at-home titration appeals to doctors, and he says that the DSMB's recommendation highlights the superior safety and tolerability of the product versus injectable Apokyn. The analyst keeps an Outperform rating on Cynapsus.
09/01/16
JANY
09/01/16
DOWNGRADE
Target $40.5
JANY
Neutral
Cynapsus Therapeutics downgraded to Neutral from Buy at Janney Capital
Janney Capital analyst Ken Trbovich downgraded Cynapsus Therapeutics to Neutral citing the company's takeover by Sunovion Pharmaceuticals. The analyst has a $40.50 price target for the shares.

TODAY'S FREE FLY STORIES

DISCA

Discovery

$29.62

0.94 (3.28%)

05:38
02/22/17
02/22
05:38
02/22/17
05:38
Downgrade
Discovery rating change  »

Discovery downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISIL

Intersil

$22.20

0.02 (0.09%)

, RNECY

Renesas

05:38
02/22/17
02/22
05:38
02/22/17
05:38
Hot Stocks
Intersil, Renesas announce regulatory approval for acquisition of Intersil »

Renesas Electronics…

ISIL

Intersil

$22.20

0.02 (0.09%)

RNECY

Renesas

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTL

Entellus Medical

$17.08

0.06 (0.35%)

05:36
02/22/17
02/22
05:36
02/22/17
05:36
Downgrade
Entellus Medical rating change  »

Entellus Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$16.05

-2.95 (-15.53%)

05:34
02/22/17
02/22
05:34
02/22/17
05:34
Downgrade
Momenta rating change  »

Leerink downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$78.44

0.66 (0.85%)

05:33
02/22/17
02/22
05:33
02/22/17
05:33
Hot Stocks
Bunge forms JV with Bahri, terms not disclosed »

Bahri Dry Bulk, or BDB, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AU

AngloGold

$12.54

-0.36 (-2.79%)

05:30
02/22/17
02/22
05:30
02/22/17
05:30
Downgrade
AngloGold rating change  »

AngloGold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$31.99

0.5 (1.59%)

05:27
02/22/17
02/22
05:27
02/22/17
05:27
Hot Stocks
Toll Brothers backs FY17 adjusted gross margin »

Toll Brothers reaffirms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

STM

STMicroelectronics

$14.64

0.38 (2.66%)

05:27
02/22/17
02/22
05:27
02/22/17
05:27
Upgrade
STMicroelectronics rating change  »

STMicroelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZSEY

Allianz

$17.45

0.13 (0.75%)

05:25
02/22/17
02/22
05:25
02/22/17
05:25
Initiation
Allianz initiated  »

Allianz initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IHG

InterContinental

$48.62

0.42 (0.87%)

05:25
02/22/17
02/22
05:25
02/22/17
05:25
Downgrade
InterContinental rating change  »

InterContinental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUKOY

Lukoil

$55.80

0.87 (1.58%)

05:24
02/22/17
02/22
05:24
02/22/17
05:24
Upgrade
Lukoil rating change  »

Lukoil upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$31.99

0.5 (1.59%)

05:23
02/22/17
02/22
05:23
02/22/17
05:23
Earnings
Toll Brothers reports Q1 EPS 42c, consensus 35c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

QCOM

Qualcomm

$56.75

0.29 (0.51%)

, CHL

China Mobile

$56.46

0.35 (0.62%)

05:17
02/22/17
02/22
05:17
02/22/17
05:17
Hot Stocks
Qualcomm, China Mobile, ZTE announce collaboration on 5G NR trials »

Qualcomm Technologies, a…

QCOM

Qualcomm

$56.75

0.29 (0.51%)

CHL

China Mobile

$56.46

0.35 (0.62%)

ZTCOY

ZTE Corp.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ECL

Ecolab

$124.03

0.08 (0.06%)

04:58
02/22/17
02/22
04:58
02/22/17
04:58
Downgrade
Ecolab rating change  »

Ecolab downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIS

General Mills

$61.02

1.79 (3.02%)

, TSN

Tyson Foods

$63.31

-1.95 (-2.99%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
The Consumer Analyst Group of New York to hold a conference »

2017 CAGNY Conference is…

GIS

General Mills

$61.02

1.79 (3.02%)

TSN

Tyson Foods

$63.31

-1.95 (-2.99%)

TWNK

Hostess Brands

$15.47

-0.13 (-0.83%)

MJN

Mead Johnson

$87.47

-0.03 (-0.03%)

K

Kellogg

$74.74

1.84 (2.52%)

MDLZ

Mondelez

$44.97

2.47 (5.81%)

INGR

Ingredion

$122.02

1.23 (1.02%)

LNCE

Snyder's-Lance

$39.38

0.38 (0.97%)

SYY

Sysco

$52.81

0.46 (0.88%)

JNJ

Johnson & Johnson

$119.66

0.8 (0.67%)

SJM

J.M. Smucker

$141.92

5.97 (4.39%)

MO

Altria Group

$73.65

0.68 (0.93%)

CPB

Campbell Soup

$58.95

0.47 (0.80%)

PEP

PepsiCo

$109.36

1.21 (1.12%)

CLX

Clorox

$135.44

1.73 (1.29%)

BG

Bunge

$78.44

0.66 (0.85%)

PG

Procter & Gamble

$91.67

0.58 (0.64%)

DANOY

Danone

$12.92

-0.125 (-0.96%)

SPB

Spectrum Brands

$134.58

0.67 (0.50%)

KO

Coca-Cola

$41.46

0.23 (0.56%)

IFF

International Flavors

$121.62

-0.75 (-0.61%)

STZ

Constellation Brands

$160.09

-1.23 (-0.76%)

NSRGY

Nestle

$72.92

-0.825 (-1.12%)

CHD

Church & Dwight

$49.61

-0.09 (-0.18%)

UN

Unilever; also tag UL

$45.09

-3.7 (-7.58%)

CL

Colgate-Palmolive

$73.18

1.2 (1.67%)

NWL

Newell Brands

$46.49

-0.15 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 24

    Feb

  • 09

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

  • 27

    Mar

  • 09

    May

RIO

Rio Tinto

$44.89

0.65 (1.47%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Rio Tinto management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 24

    Feb

  • 26

    Feb

CRUS

Cirrus Logic

$55.17

-0.16 (-0.29%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Cirrus Logic management to meet with Canaccord »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

VWDRY

Vestas

$24.97

0.34 (1.38%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Vestas management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MPWR

Monolithic Power

$88.22

1.7 (1.96%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Monolithic Power management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 04

    Apr

  • 05

    Apr

WEB

Web.com

$20.40

0.2 (0.99%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Web.com management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

OCLR

Oclaro

$10.97

-0.05 (-0.45%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Oclaro management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 03

    Mar

HAS

Hasbro

$98.88

0.38 (0.39%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
Hasbro management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

FLWS

1-800-Flowers.com

$10.10

0.1 (1.00%)

04:55
02/22/17
02/22
04:55
02/22/17
04:55
Conference/Events
1-800-Flowers.com management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

04:55
02/22/17
02/22
04:55
02/22/17
04:55
General news
Breaking General news story  »

FOMC Minutes to be…

04:55
02/22/17
02/22
04:55
02/22/17
04:55
General news
Breaking General news story  »

Federal Reserve Gov.…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.